Differential expression of chemokines and chemokine receptors in inflammatory periapical diseases

Oral Microbiology and Immunology

Volumn 20, Issue 5, 2005, Pages 310-316

  Silva, T A ^a,c   Garlet, G P ^a   Lara, V S ^a   Martins Jr , W ^b   Silva, J S ^a   Cunha, F Q ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF RIBEIRÃO PRETO   (Brazil)

^c UNIVERSITY OF BRASILIA   (Brazil)

Author keywords

Chemokines; Periapical cyst; Periapical granuloma

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES;

ADULT; ARTICLE; CONTROLLED STUDY; CYST; GENE EXPRESSION; GINGIVA; GRANULOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TH1 CELL; TH2 CELL; TOOTH PERIAPICAL DISEASE;

ADULT; AGED; CHEMOKINE CCL2; CHEMOKINES; CHEMOKINES, CC; CHEMOKINES, CXC; CHEMOTAXIS, LEUKOCYTE; GINGIVA; HUMANS; INTERLEUKIN-8; LEUKOCYTES; MACROPHAGE INFLAMMATORY PROTEIN-1; MIDDLE AGED; PERIAPICAL GRANULOMA; PERIAPICAL PERIODONTITIS; RADICULAR CYST; RANTES; RECEPTORS, CCR5; RECEPTORS, CHEMOKINE; RECEPTORS, HIV; RECEPTORS, INTERLEUKIN-8A; T-LYMPHOCYTES;

EID: 23944520562     PISSN: 09020055     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-302X.2005.00232.x     Document Type: Article

References (31)

1. Balto K, Sasaki H, Stashenko P. Interleukin-6 deficiency increases inflammatory bone destruction. Infect Immun 2001: 69: 744-750.
2. Bonecchi R, Bianchi G, Bordignon PP, D'Ambrosio D, Lang R, Borsatti A, et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 1998: 187: 129-134.
3. Chae P, Im M, Gibson F, Jiang Y, Graves DT. Mice lacking monocyte chemoattractant protein 1 have enhanced susceptibility to an interstitial polymicrobial infection due to impaired monocyte recruitment. Infect Immun 2002: 70: 3164-3169.
4. Farber JM. Mig and IP-10: CXC chemokines that target lymphocytes. J Leukoc Biol 1997: 61: 246-257.
5. Garlet GP, Martins W Jr, Ferreira BR, Milanezi CM, Silva JS. Patterns of chemokines and chemokine receptors expression in different forms of human periodontal disease. J Periodontal Res 2003: 38: 210-217.
6. Gu L, Tseng S, Horner RM, Tam C, Loda M, Rollins BJ. Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1. Nature 2000: 404: 407-411.
7. Jankovic D, Liu Z, Cause WC. Th1- and Th2-cell commitment during infectious disease: asymmetry in divergent pathways. Trends Immunol 2001: 22: 450-457.
8. Kabashima H, Nagata K, Maeda K, Iijima T. Presence of IFN-gamma and IL-4 in human periapical granulation tissues and regeneration tissues. Cytokine 2001: 14: 289-293.
9. Kabashima H, Yoneda M, Nagata K, Hirofuji T, Ishihara Y, Yamashita M, et al. The presence of chemokine receptor (CCR5, CXCR3, CCR3)-positive cells and chemokine (MCP1, MIP-1alpha, MIP-1beta, IP-10)-positive cells in human periapical granulomas. Cytokine 2001: 16: 62-66.
10. Kaplan G, Luster AD, Hancock G, Cohn ZA. The expression of a gamma interferon-induced protein (IP-10) in delayed immune responses in human skin. J Exp Med 1987: 166: 1098-1108.
11. Karpus WJ, Kennedy KJ. MIP-1alpha and MCP-1 differentially regulate acute and relapsing autoimmune encephalomyelitis as well as Th1/Th2 lymphocyte differentiation. J Leukoc Biol 1997: 62: 681-687.
12. Kawashima N, Stashenko P. Expression of bone-resorptive and regulatory cytokines in murine periapical inflammation. Arch Oral Biol 1999: 44: 55-66.
13. Ko HJ, Lim SS. Production of macrophage inflammatory protein (MIP)-1alpha and MIP-1beta by human polymorphonuclear neutrophils stimulated with Porphyromonas endodontalis lipopolysaccharide. J Endod 2002: 11: 754-757.
14. Liapatas S, Nakou M, Rontogianni D. Inflammatory infiltrate of chronic periradicular lesions: an immunohistochemical study. Int Endod J 2003: 36: 464-471.
15. Loetscher P, Pellegrino A, Gong JH, Mattioli I, Loetscher M, Bardi G, et al. The ligands of CXC chemokine receptor 3, I-TAC, Mig, and IP10, are natural antagonists for CCR3. J Biol Chem 2001: 276: 2986-2991.
16. Loetscher P, Uguccioni M, Bordoli L, Baggiolini M, Moser B, Chizzolini C, et al. CCR5 is characteristic of Th1 lymphocytes. Nature 1998: 391: 344-345.
17. Marton IJ, Rot A, Schwarzinger E, Szakall S, Radics T, Valyi-Nagy I, et al. Differential in situ distribution of interleukin-8, monocyte chemoattractant protein-1 and RANTES in human chronic periapical granuloma. Oral Microbiol Immunol 2000: 15: 63-65.
18. Menzies-Gow A, Ying S, Sabroe I, Stubbs VL, Soler D, Williams TJ, et al. Eotaxin (CCL11) and eotaxin-2 (CCL24) induce recruitment of eosinophils, basophils, neutrophils, and macrophages as well as features of early- and late-phase allergic reactions following cutaneous injection in human atopic and nonatopic volunteers. J Immunol 2002: 169: 2712-2718.
19. Nair PN. Apical periodontitis: a dynamic encounter between root canal infection and host response. Periodontol 2000 1997: 13: 121-148.
20. Proudfoot AE, Power CA, Rommel C, Wells TN. Strategies for chemokine antagonists as therapeutics. Semin Immunol 2003: 15: 57-65.
21. + T cells in human granulomas and periapical cysts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001: 92: 221-227.
22. Rossi D, Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol 2000: 18: 217-242.
23. Sallusto F, Lanzavecchia A, Mackay CR. Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol Today 1998: 19: 568-574.
24. Sallusto F, Lenig D, Mackay CR, Lanzavecchia A. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med 1998: 187: 875-883.
25. Sallusto F, Mackay CR, Lanzavecchia A. The role of chemokine receptors in primary, effector, and memory immune responses. Annu Rev Immunol 2000: 18: 593-620.
26. Sasaki H, Balto K, Kawashima N, Eastcott J, Hoshino K, Akira S, et al. Gamma interferon (IFN-gamma) and IFN-gamma-inducing cytokines interleukin-12 (IL-12) and IL-18 do not augment infection-stimulated bone resorption in vivo. Clin Diagn Lab Immunol 2004: 11: 106-110.
27. Sasaki H, Hou L, Belani A, Wang CY, Uchiyama T, Muller R, et al. IL-10, but not IL-4, suppresses infection-stimulated bone resorption in vivo. J Immunol 2000: 165: 3626-3630.
28. Shimauchi H, Takayama S, Narikawa-Kiji M, Shimabukuro Y, Okada H. Production of interleukin-8 and nitric oxide in human periapical lesions. J Endod 2001: 12: 749-752.
29. Votta BJ, White JR, Dodds RA. CKbeta-8 [CCL23], a novel CC chemokine, is chemotactic for human osteoclast precursors and is expressed in bone tissues. J Cell Physiol 2000: 183: 196-207.
30. Wise GE, Que BG, Huang H. Synthesis and secretion of MCP-1 by dental follicle cells - implications for tooth eruption. J Dent Res 1999: 78: 1677-1681.
31. Yang LC, Huang FM, Lin CS, Liu CM, Lai CC, Chang YC. Induction of interleukin-8 gene expression by black-pigmented Bacteroides in human pulp fibroblasts and osteoblasts. Int Endod J 2003: 36: 774-779.